Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7501 p555-560
10 May 2008

This section
Reprint   Photocopy

PDF 180K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events

Pages: 555   556   557   558   559   560 

555 Society sets out next steps for professional body Pharmacists will be consulted on the Royal Pharmaceutical Society’s work on a new professional body for pharmacy, according to a briefing document for members, issued by the Society this week
PJ 2008;280:555
Full Text

555 First pharmacists with special interests accredited in anticoagulation Two pharmacists in Bradford have become the first to qualify as pharmacists with special interests (PhwSIs) in England, it was announced this week
PJ 2008;280:555
Full Text

555 Clinical assessment service to extend function to poorly performing NHS pharmacists The National Clinical Assessment Service, which currently provides advice and support for the NHS for dealing with poorly performing doctors and dentists, is to extend its function to include pharmacists in England from April 2009
PJ 2008;280:555
Full Text



556 Users say summary care record is “too complex” An independent evaluation of the patient summary care record (SCR) has reached mixed conclusions, according to its report published this week
PJ 2008;280:556
Full Text

556 Pharmacy staff do not respect drug misusers A significant number of drug misuse service users feel that pharmacy staff do not respect them, according to findings released by the Healthcare Commission and the National Treatment Agency this week
PJ 2008;280:556
Full Text

556 DoH sets out details for human papillomavirus vaccinations Details of the Government’s plans to introduce human papillomavirus vaccine into the national immunisation programme in England were set out in a letter sent to healthcare professionals last week
PJ 2008;280:556
Full Text

556 MHRA safety update Safety profiles of the anti-obesity drug rimonabant (Acomplia) and the incretin mimetic exenatide (Byetta) are the focus of May 2008’s Drug Safety Update published by the Medicines and Healthcare products Regulatory Agency
PJ 2008;280:556
Full Text

556 Prescribing profiles Six pharmacist prescribing case studies have been published on the Department of Health website to help the NHS understand how non-medical prescribing can help to deliver services
PJ 2008;280:556
Full Text

556 Saturday opening for NPA The National Pharmacy Association’s information service will open on Saturday mornings from this weekend
PJ 2008;280:556
Full Text



557 Judicial review ruling could slow NICE appraisals Drug appraisals by the National Institute for Health and Clinical Excellence, which govern prescribing guidance in England and Wales, may take longer in the future following what is being seen as a landmark Court of Appeal ruling
PJ 2008;280:557
Full Text

557 Low-strength Kaletra tablets launched for children infected with HIV Children prescribed lopinavir/ritonavir (Kaletra) to treat HIV could find it easier to take their medicines with the launch of a low-strength Kaletra film-coated tablet (100mg/25mg)
PJ 2008;280:557
Full Text

557 Cases of drug-resistant tuberculosis on the increase in the UK Changes in the population and ongoing migration have increased cases of drug-resistant tuberculosis in the UK, according to a new study
PJ 2008;280:557
Full Text



558 Views sought on dismantling blister packs in advance Pharmacists are being asked whether professional guidelines should be changed to allow the removal of medicines from blister or foil packs in advance of them being dispensed to patients. The Royal Pharmaceutical Society is suggesting that the change be written into guidance which supports the profession’s code of ethics because the current clause is out of step with the modern practices of robotic dispensing and monitored dosage systems (MDS)
PJ 2008;280:558
Full Text

558 Self care principles for health and social care Seven core principles to support self care have been published by the Government. They are intended for use by the health and social care workforce in England to help people live independently and manage their own conditions
PJ 2008;280:558
Full Text

558 Healthy Start vitamins to be supplied through community pharmacies in Scotland Community pharmacies in Scotland are set to have a key role in supplying vitamins through the Healthy Start scheme
PJ 2008;280:558
Full Text

558 National Association of Women Pharmacists champions pharmacies as gateway for carers Support for carers through a project initiated by the National Association of Women Pharmacists has been piloted in Wales. The project, launched in 12 pharmacies and 25 GP practices across Cardiff, followed a suggestion made by the Princess Royal at the NAWP centenary lunch in July 2005 that pharmacists could help the UK’s six million carers
PJ 2008;280:558
Full Text



559 Trial hints at improved safety for novel psoriasis drug ISA247, a novel calcineurin inhibitor, is safe and effective in the treatment of patients with moderate to severe psoriasis and may have an improved safety profile compared with ciclosporin, according to the authors of a phase III study published
PJ 2008;280:559
Full Text

559 Corticosteroids do not improve infant survival in bacterial meningitis Using adjuvant corticosteroids to treat bacterial meningitis does not reduce the risk of infected children dying, a study published this week shows
PJ 2008;280:559
Full Text

559 Metformin safe and effective to treat diabetes that develops in pregnancy, say researchers Metformin is a safe and effective treatment for women with gestational diabetes mellitus, a study published this week confirms
PJ 2008;280:559
Full Text



560 Cilostazol as effective as aspirin Cilostazol, an investigational antiplatelet drug, is as effective as aspirin for the secondary prevention of ischaemic stroke and is associated with fewer bleeding events, according to a study in China. However, a larger study is needed to confirm the findings, say the researchers
PJ 2008;280:560
Full Text

560 Fluoxetine could benefit patients with multiple sclerosis Fluoxetine has a tendency to reduce the formation of new brain lesions over time in patients with multiple sclerosis (MS), preliminary research published online reveals
PJ 2008;280:560
Full Text

560 Tarenflurbil mixed success in AD Tarenflurbil has shown some benefit in the mild stages of Alzheimer’s disease in a phase II study, published online
PJ 2008;280:560
Full Text

560 HIV research Researchers have shown that in vitro inhibition of a cellular protein, inducible T-cell kinase (ITK), can block HIV replication at multiple steps: HIV gene transcription, viral entry and viral particle production and release
PJ 2008;280:560
Full Text

560 Everolimus stent shows promise Use of everolimus — an experimental macrolide immunosuppressant — in drug-eluting stents, has been tested in a 1,002-patient trial, reported recently
PJ 2008;280:560
Full Text

560 Potential metastatic cancer strategy Combination of bortezomib with MD5-1 — a tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor agonist monoclonal antibody — could be a useful strategy for treating metastatic solid tumours, the authors of a new study suggest
PJ 2008;280:560
Full Text

Back to Top


©The Pharmaceutical Journal